News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

December 18, 2024

How ECOG-ACRIN and Caris Life Sciences are teaming up to fight cancer

December 13, 2024

Tamoxifen cuts 15-year recurrence in DCIS without radiation therapy

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 11, 2024

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

November 26, 2024

The November 2024 News from ECOG-ACRIN blog is now available

November 25, 2024

Press Release: Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

November 22, 2024

Press Release: ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 29, 2024

WATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

October 25, 2024

ECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)

October 24, 2024

The October 2024 News from ECOG-ACRIN blog is now available

October 24, 2024

Press Release: ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial

October 23, 2024

Press Release: myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across the US and Canada

October 15, 2024

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

 
ECOG-ACRIN Cancer Research Group